Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Genetic Tech Spn ADR (NQ: GENE )

0.7300 -0.0200 (-2.67%)
Streaming Delayed Price Updated: 9:50 AM EDT, Oct 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Genetic Tech Spn ADR

< Previous 1 2 3 4 5 6 7 8 Next >
Bullish Thursday For Marijuana Stocks - Australis Capital, Choom Holdings Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Annual Results – Momentum Building on our Commercial Plans
From Genetic Technologies Ltd
Via GlobeNewswire
Cannabis Stock Movers For August 29, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Genetic Technologies Limited Announces Updated Investor Presentation
From Genetic Technologies Ltd
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
  On Friday, 73 companies reached new 52-week lows. 
Via Benzinga
Quarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
From Genetic Technologies Ltd
Via GlobeNewswire
Cannabis Stock Gainers And Losers From July 14, 2023
Via Benzinga
GeneType featured on U.S. National TV to raise Breast Cancer Awareness
From Genetic Technologies Ltd
Via GlobeNewswire
New Publication Validates geneType for Melanoma Risk Assessment
From Genetic Technologies Ltd
Via GlobeNewswire
Quarterly Business Update – March 2023
Driving growth, Expanded Multi-Test Panel and Publications Validating Clinical Utility of geneType 
From Genetic Technologies Ltd
Via GlobeNewswire
Publication Validates geneType Prostate Cancer Risk Test
From Genetic Technologies Ltd
Via GlobeNewswire
GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation
From Genetic Technologies Ltd
Via GlobeNewswire
Back-to-back Studies Validate geneType Breast Cancer Risk Test
From Genetic Technologies Ltd
Via GlobeNewswire
Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 120.5% to $1.02 after jumping over 72% on Friday. 
Via Benzinga
Why Blue Apron Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 52.5% to $0.7050 in pre-market trading after jumping over 72% on Friday. 
Via Benzinga
Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday. 
Via Benzinga
Why Cardiovascular Systems Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
New Publication Highlights geneType’s Ability to Detect Breast Cancer Earlier and Provide Data for Risk Stratification
From Genetic Technologies Ltd
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off another day of trading with a look at the biggest pre-market stock movers investors need to watch for Wednesday! 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with an overview of the biggest pre-market stock movers traders need to know about for Monday! 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Is Gaucho Group (VINO) Stock Down 35% Today?
Gaucho Group (VINO) stock is falling hard on Friday after the e-commerce company announced a new $44 million ELOC yesterday. 
Via InvestorPlace
Why Is MDxHealth (MDXH) Stock Down 40% Today?
MDxHealth (MDXH) stock is falling on Friday after the healthcare company revealed plans for a proposed public stock offering. 
Via InvestorPlace
Why Is Edible Garden (EDBL) Stock Down 45% Today?
Edible Garden (EDBL) stock is falling hard on Friday as investors react to the details of a proposed public stock offering. 
Via InvestorPlace
Why Is Genetic Technologies (GENE) Stock Up 173% Today?
Genetic Technologies (GENE) stock is taking off on Friday as the company prepares for new cancer test areas with a collaboration. 
Via InvestorPlace
Genetic Technologies Announces $5 Million Registered Direct Offering
From Genetic Technologies Ltd
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer
From Genetic Technologies Ltd
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.